1Report on cardiovascular health and diseases in China 2024:Epidemiological status of cardiovascular diseases and their risk factorsThe Writing Committee of the Report on Cardiovascular Health and Diseases in China 2024, WANG Zeng-wuGuideline and Consensus771-7932Report on cardiovascular health and diseases in China 2024:Diagnosis and Treatment Status of Arrhythmia and Heart FailureThe Writing Committee of the Report on Cardiovascular Health and Diseases in China 2024, WANG Zeng-wuGuideline and Consensus794-8033Predictive value of the age-adjusted charlson comorbidity index for cardiogenic death in patients with heart failure with reduced ejection fractionZHAO Chun-xiu, ZHANG Xue-he, SUN Hua-xin, WANG Zhong, WANG Han-xiao, KANG Sheng-nan, ZHANG Tong, ZHANG ChuanHeart failure804-8104Study on machine learning-based mortality prediction models for hypertensive heart failureWANG Miao, FAN Hong-xuan, WANG Lei-gang, REN Zhao-yu, LIANG BinHeart failure811-8185Construction of prediction model and risk stratification for heart failure complications in acute myocardial infarction patients based on big medical test dataCAO Wei, YANG Zhi-ning, JI Bing, WANG Li-juanHeart failure819-8246Expression and significance of serum CXC chemokine ligand 12,poly ADP-ribose polymerase 1 and Kruppel-like factor 15 in patients with chronic heart failurePENG Qing, XIAO Yao, NI Li-tingHeart failure825-8307Abnormal expression of serum biomarkers in assessing cardiac function and prognosis in heart failure patients complicated with pulmonary infectionBAI Xian-ying, LI Ke-fan, LIU Xiang-qin, XUE Yun, ZHANG Jing-meiHeart failure831-8358Progress in the treatment of heart failure after myocardial infarctionWANG Xiao, WANG Jing-yao, YANG Yan-li, LEI Meng-jie, LI Ya-chao, LI Cai-rong, ZHAO Zhi-gang, XUE Zeng-mingReview836-8429Insulin resistance in heart failure with preserved ejection fraction:Mechanisms and advances in metabolic-targeted therapiesYANG Niao, MEI Chao-sheng, MIN Xuan, QIN Cui-minReview843-84810Advances in the use and study of fenelidone in the treatment of heart failureZHOU Yu-fei, ZHANG Ya-hao, JIANG Shu-binReview849-85411Research progress of vericiguat combined withnew quadrupledrugs in the treatment of chronic heart failureZHOU Ming-hao, SI Dao-yuan, HE Yu-quanReview855-86012Inflammation in panvascular diseases:mechanisms and research AdvancesLI Rui-yuan, GUO Li-peng, ZHANG YiReview861-866 